Cargando…
The use of indocyanine green as the only tracer for the identification of the sentinel lymph node in breast cancer: safety and feasibility
BACKGROUND: Sentinel lymph node biopsy (SLNB) is now considered the “gold standard” for axillary staging in the treatment of breast cancer. Most of the lymph node mapping experiences have been performed with a radioisotope (albumin-Tc99m) associated or not with the intraoperative injection of a dye,...
Autores principales: | Pellini, Francesca, Bertoldi, Lorenzo, Deguidi, Giulia, Perusi, Nicola, Caldana, Marina, De Flaviis, Mattia, Di Paolo, Serena, Mirandola, Sara, Tombolan, Valeria, Zambelli Sopalu, Sabrina, Invento, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346226/ https://www.ncbi.nlm.nih.gov/pubmed/35935557 http://dx.doi.org/10.21037/gs-21-609 |
Ejemplares similares
-
Stannous colloid mixed with indocyanine green as a tracer for sentinel lymph node navigation surgery
por: Zhang, Yiting, et al.
Publicado: (2022) -
Preparation study of indocyanine green-rituximab: A new receptor-targeted tracer for sentinel lymph node in breast cancer
por: Cong, Bin-Bin, et al.
Publicado: (2016) -
Sentinel lymph node mapping with indocyanine green in vaginal cancer
por: Lee, In Ok, et al.
Publicado: (2017) -
Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial
por: Nguyen, Chu Luan, et al.
Publicado: (2023) -
The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
por: Kim, Ju-Hyun, et al.
Publicado: (2018)